## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Synthesis of racemic, S(+)- and R(-)-N-[methyl-3H]3,4-methylenedioxymethamphetamine
✍ Scribed by Kenji Hashimoto; Katsumi Hirai; Tsuyoshi Goromaru
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 158 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The synthesis of 3,4‐methylenedioxymethamphetamine(MDMA), a serotonergic neurotoxin, labeled with tritium is described. Labeling was accomplished by N‐alkylation of the free base of the corresponding desmethyl compound using [^3^H]methyl iodide. The compound was purified by preparative HPLC. The radiochemical yield was about 60% based on [^3^H]methyl iodide. The radiochemical purity was more than 95% from HPLC and TLC. Furthermore, S(+)‐ and R(‐)‐[^3^H]MDMA were completely separated by analytical HPLC with chiral column.
📜 SIMILAR VOLUMES
## Abstract Subsequent to the discovery that the (+)‐benzomorphan sigma receptor ligands, (+)‐pentazocine and (+)‐N‐allylnormetazocine, stimulated tyrosine hydroxylase activity and dopamine synthesis in rat striatum __in vitro__, we reported a similar effect on a structurally similar series of 1‐ph
N-Substituted (3S,4S)-and (3R,4R)-pyrrolidine-3,4-diols 9 and 10, respectively, were derived from ()-land (À)-d-tartaric acid, respectively. Compounds 9k, 9l, and 9m with the N-substituents, BnNH(CH 2 ) 2 , 4-PhC 6 H 4 CH 2 NH(CH 2 ) 2 and 4-ClC 6 H 4 CH 2 NH(CH 2 ) 2 , respectively, showed modest i
## Abstract The syntheses of 3‐methyl‐4‐phenyl‐3‐butenamide, an hypolipemic compound, labelled 1‐^14^C (VIII) and N,N‐dideutero (XI) are described. The 2‐methyl‐3‐phenyl‐2‐propenyl chloride (VI), reacting with cuprous cyanide‐^14^C, gave the 3‐methyl‐4‐phenyl‐3‐butenonitrile‐1‐^14^C (VII) which, tr
## Abstract The preparation of the title compound, a selective serotonin uptake inhibitor with antidepressant properties in man, is described. The preparation of the 7‐bromo precursor via a stereoselective seven‐step sequence from (1R)‐7‐bromo‐1,2,3,4‐tetrahydro‐N‐methyl‐1‐naphthalenamine is descri